4WQ-19834-31435
4 vaccinations
12 coded responses
37 check-ins
11 free-text entries
6 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 028 / RI
- Registered
- 2021-02-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-24
Registered in v-safe
-
2021-02-24
Dose 1 — Pfizer-BioNTech
- 2021-02-24
-
2021-02-26
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Joint pains, Fatigue or tirednessAdult check-in
-
2021-02-27
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-28
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-03-03
-
2021-03-10
Survey response — day 14, dose 1MedDRA: Alopecia, Anosmia, Fatigue, Feeling abnormal, Headache, Neuralgia, Pain, Painful respiration, Parosmia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Loss of Sense of smell has gotten worse, but experiencing fewer phantom odors. Other symptoms recur when tired (headache, body aches, nerve pain in arms and legs, painful breathing, brain fog). But hair loss is decreasing.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Survey response — day 21, dose 1MedDRA: Alopecia, Headache, Neck pain, Parosmia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Sense of smell has worsened (it had previously slightly improved but is now the worst its been). Hair loss has increased. Neck pain and headaches have returned.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Dose 2 — Pfizer-BioNTech
- 2021-03-24
-
2021-03-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness, Swelling · Joint pains, Muscle or body aches, NauseaAdult check-in
-
2021-03-27
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, NauseaAdult check-in
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-07
- 2021-04-14
-
2021-04-21
Survey response — day 28, dose 2MedDRA: Pain, Pain in extremity, Paraesthesia, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Still no sense of smell. Continue to have nerve issues of pain and tingling in arms, legs, feet (which began during onset of being infected in Nov 2020). Pain has become worseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-28
Survey response — day 35, dose 2MedDRA: Arthralgia, Fatigue, Headache, Hyposmia, Neuralgia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Joint pain. Still minimal sense of smell. Headaches and nerve pain in arms and legs. Fatigue.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-05
- 2021-06-23
-
2021-09-22
Survey response — 6 months, dose 2MedDRA: Arthralgia, Condition aggravated, Dyspnoea, Headache, Joint swelling, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Headaches, swollen painful joints, difficult breathing(despite med, Advair,and inhaler)and nerve pain that started when I had COVID continue. If I get tired they get very bad for days.MedDRA releases: 2024-11 · check-in free text available
-
2021-09-22
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-24
-
2021-09-27
Dose 3 — Pfizer-BioNTech
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-04
Health check-in — day 7, dose 3Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-11
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-12-27
-
2022-03-30
Survey response — 6 months, dose 3MedDRA: COVID-19, Eye irritation, Eye swelling — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Swelling in eyes and return of the irritation that first occurred when I had COVID.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-30
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-04
-
2022-04-07
Call successfulParticipant prefers to complete VAERS report online
-
2022-04-07
Call successfulParticipant prefers to complete VAERS report online
-
2022-04-11
Dose 4 — Pfizer-BioNTech
-
2022-05-15
Survey response — day 28, dose 4MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: After the 4th dose I have not been able to control fibromyalgia symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-05-15
Report sent to call center — day 28, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-05-16
Survey response — day 35, dose 4MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Unable to get control of fibromyalgia symptoms since having 2nd boosterMedDRA releases: 2024-11 · check-in free text available
-
2022-05-16
Call successfulParticipant prefers to complete VAERS report online
-
2022-05-23
Survey response — day 42, dose 4MedDRA: Condition aggravated, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Muscle and nerve pain, fatigue associated with fibromyalgia. Since getting the second booster I have not been able to get fibromyalgia under control.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-11
Survey response — 3 months, dose 4MedDRA: Condition aggravated, Office visit, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: I believe my last booster in March triggered my fibromyalgia. It took 3 months to finally feel better. · Healthcare visit (other): Primary dr, allergist, and rheumatologistMedDRA releases: 2024-11 · check-in free text available
-
2022-07-11
Report sent to call center — 3 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-07-12
Call successfulParticipant prefers to complete VAERS report online
-
2022-10-10
Survey response — 6 months, dose 4MedDRA: Arthralgia, Condition aggravated, Dyspnoea, Insomnia, Office visit, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Difficulty breathing. Pain in hips and knees. Difficulty sleeping. Fibromyalgia kicked in and has persisted since last COVID vaccination. · Healthcare visit (other): Office Visit with rheumatologistMedDRA releases: 2024-11 · check-in free text available
-
2022-10-10
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2022-10-11
Call successfulParticipant prefers to complete VAERS report online
-
2023-04-11
Survey response — 12 months, dose 4MedDRA: Alopecia, COVID-19, Condition aggravated, Pre-existing disease, Thrombosis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationMedDRA releases: 2024-11
-
2023-04-11
Report sent to call center — 12 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2023-04-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-24 | Pfizer-BioNTech | |
| 2 | 2021-03-24 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | No |
| 4 | 2022-04-11 | Pfizer-BioNTech | No |
Call center
6 call center cases
5 successful · 1 unsuccessful
VAERS report filed, before or during a call: 1
Free text
Release 5 — day 14, dose 1
Symptoms: Loss of Sense of smell has gotten worse, but experiencing fewer phantom odors. Other symptoms recur when tired (headache, body aches, nerve pain in arms and legs, painful breathing, brain fog). But hair loss is decreasing.
Release 5 — day 21, dose 1
Symptoms: Sense of smell has worsened (it had previously slightly improved but is now the worst its been). Hair loss has increased. Neck pain and headaches have returned.
Release 7 — day 28, dose 2
Symptoms: Still no sense of smell. Continue to have nerve issues of pain and tingling in arms, legs, feet (which began during onset of being infected in Nov 2020). Pain has become worse
Release 8 — day 35, dose 2
Symptoms: Joint pain. Still minimal sense of smell. Headaches and nerve pain in arms and legs. Fatigue.
Release 9 — 6 months, dose 2
Symptoms: Headaches, swollen painful joints, difficult breathing(despite med, Advair,and inhaler)and nerve pain that started when I had COVID continue. If I get tired they get very bad for days.
Release 11 — 6 months, dose 3
Symptoms: Swelling in eyes and return of the irritation that first occurred when I had COVID.
Release 11 — day 28, dose 4
Symptoms: After the 4th dose I have not been able to control fibromyalgia symptoms
Release 11 — day 35, dose 4
Symptoms: Unable to get control of fibromyalgia symptoms since having 2nd booster
Release 11 — day 42, dose 4
Symptoms: Muscle and nerve pain, fatigue associated with fibromyalgia. Since getting the second booster I have not been able to get fibromyalgia under control.
Release 12 — 3 months, dose 4
Symptoms: I believe my last booster in March triggered my fibromyalgia. It took 3 months to finally feel better.
Healthcare visit (other): Primary dr, allergist, and rheumatologist
Release 12 — 6 months, dose 4
Symptoms: Difficulty breathing. Pain in hips and knees. Difficulty sleeping. Fibromyalgia kicked in and has persisted since last COVID vaccination.
Healthcare visit (other): Office Visit with rheumatologist
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Alopecia | ✓ | ✓ | ✓ |
| SD | Anosmia | ✓ | ✓ | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Eye irritation | · | · | ✓ |
| SD | Eye swelling | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Feeling abnormal | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hyposmia | ✓ | ✓ | ✓ |
| SD | Insomnia | · | · | ✓ |
| SD | Joint swelling | · | · | ✓ |
| SD | Neck pain | ✓ | ✓ | ✓ |
| SD | Neuralgia | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pain in extremity | ✓ | ✓ | ✓ |
| SD | Painful respiration | ✓ | ✓ | ✓ |
| SD | Paraesthesia | ✓ | ✓ | ✓ |
| SD | Parosmia | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Thrombosis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release